At baseline, they were 6.4% for each group. At 4 years, they were 6.1% and 6.4% for the glargine and standard care arms, respectively, and at the conclusion of the study they were 6.2% and 6.5%, respectively. The ORIGIN (Outcome Reduction with Red Bottom Heels an Initial Glargine Intervention) trial…